CP-122721 Uses, Dosage, Side Effects and more
CP-122721, neurokinin 1 (NK1) antagonist is developed by Pfizer to treat depression, emesis, and inflammatory diseases including asthma and irritable bowel syndrome.
| Trade Name | CP-122721 |
| Generic | CP-122721 |
| Type | |
| Formula | C20H23F3N2O2 |
| Weight | Average: 380.404 Monoisotopic: 380.171162605 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in asthma, depression, and irritable bowel syndrome (IBS).
How CP-122721 works
CP-122721 interacts with high affinity at the human NK1 receptor expressed in IM-9 cells.
